Australia Yields Hit Highest Since 2014 With RBA, Fed Hikes Seen
(Bloomberg) -- Australian bonds sold off as investors anticipate the nation's central bank will raise interest rates on Tuesday for the first time since 2010.
Yields on benchmark 10-year government notes jumped 14 basis points to 3.26%, the highest since November 2014. The premium over similar-dated Treasuries rose to 32 basis points, up 13 basis points from Friday, according to data compiled by Bloomberg.
Bonds are tumbling worldwide this year as central banks move to aggressively tighten policy to counter elevated inflation. The Bloomberg Global Aggregate Total Return Index lost 5.5% in April, the biggest monthly drop since its inception in 1990. Investors are pricing in a half-point increase by the Federal Reserve on Wednesday, its steepest hike since 2000.
Bond Traders Face Week That Threatens to Shatter Any Market Calm
“Australian bonds have under-performed to reflect the market's confidence that the RBA will now deliver its first hike of the cycle this week,” said Andrew Ticehurst, a rates strategist in Sydney at Nomura Holdings Inc. “Stronger-than-expected U.S. wages data led markets to conclude that central banks will be forced to stay on the hawkish path, and will seek to get back to the relative safety of neutral policy settings, as quickly as they can.”
Treasury 10-year yields were little changed on Monday at 2.94%. They climbed about 11 basis points on Friday after the U.S. employment cost index surged by a record 1.4% in the first quarter. Swaps traders are pricing in four straight half-point hikes by the Fed to take its benchmark rate to 2.33% by the end of its September meeting.
Australian traders are also expecting aggressive moves from the RBA. Overnight-index swaps see the cash-rate target at 2.5% by year-end, from a record-low 0.1%, which would be the sharpest annual increase since 1994. That also implies at least two occasions when the central bank raises rates by more than a quarter point.
Australian Policy Makers Take Election Center Stage in Rate Call
©2022 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
